Nitric oxide synthase isoforms in lung parenchyma of patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 1, 2010, Pages 3-4

  Corradi, Massimo ^a   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AIRWAY; CACHEXIA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; EDITORIAL; EMPHYSEMA; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; ISCHEMIA; LIVER INJURY; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG PARENCHYMA; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATORY SYSTEM; SKELETAL MUSCLE; VITAL CAPACITY;

BREATH TESTS; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; HUMANS; ISOENZYMES; NITRIC OXIDE SYNTHASE TYPE II; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UP-REGULATION;

EID: 73849130681     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200908-1279ED     Document Type: Editorial

References (13)

1. Beg MF, Alzoghaibi MA, Abba AA, Habib SS. Exhaled nitric oxide in stable chronic obstructive pulmonary disease. Ann Thoracic Med 2009;4:65-70.
2. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-424.
3. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:998-1002.
4. Roy K, Borrill ZL, Starkey C, Hazel AL, Morris J, Vestbo J, Singh D. Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J 2007;29:651-659.
5. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005;26:52-59.
6. Brindicci C, Kharitonov SA, Ito M, Elliott MW, Hogg JC, Barnes PJ, Ito K. Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease. Am J Respir Crit CareMed 2010;181:21-30.
7. Brindicci C, Ito K, Torre O, Barnes PJ, Kharitonov SA. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients. Chest 2009;135:353-367.
8. Redington AE. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur J Pharmacol 2006;533:263-276.
9. Maestrelli P, Páska C, Saetta M, Turato G, Nowicki Y, Monti S, Formichi B, Miniati M, Fabbri LM. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 2003;21:971-976.
10. Ryter SW, Kim HP, Nakahira K, Zuckerbraun BS, Morse D, Choi AM. Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system. Antioxid Redox Signal 2007;9: 2157-2173.
11. Lin HI, Chou SJ, Wang D, Feng NH, Feng E, Chen CF. Reperfusion liver injury induces down-regulation of eNOS and up-regulation of iNOS in lung tissues. Transplant Proc 2006;38:2203-2206.
12. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162: 701-716.
13. Agusti A, Morla M, Sauleda J, Saus C, Busquets JNF. -kB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004;59:483-487.